A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Illumina, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 945,400 shares of ILMN stock, worth $147 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
945,400
Previous 388,000 143.66%
Holding current value
$147 Million
Previous $53.3 Million 85.21%
% of portfolio
0.23%
Previous 0.13%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.05 - $133.57 $56.3 Million - $74.5 Million
557,400 Added 143.66%
945,400 $98.7 Million
Q1 2024

May 15, 2024

BUY
$127.73 - $147.2 $3.09 Million - $3.56 Million
24,200 Added 6.65%
388,000 $53.3 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $31.7 Million - $48.6 Million
341,100 Added 1502.64%
363,800 $50.7 Million
Q3 2023

Nov 14, 2023

SELL
$128.91 - $192.44 $6.86 Million - $10.2 Million
-53,200 Reduced 70.09%
22,700 $3.12 Million
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $84 Million - $107 Million
-458,000 Reduced 85.78%
75,900 $14.2 Million
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $3.04 Million - $3.65 Million
-15,700 Reduced 2.86%
533,900 $124 Million
Q4 2022

Feb 14, 2023

SELL
$187.24 - $242.74 $66.8 Million - $86.6 Million
-356,900 Reduced 39.37%
549,600 $111 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $24.5 Million - $31.5 Million
138,400 Added 18.02%
906,500 $173 Million
Q2 2022

Aug 15, 2022

BUY
$181.58 - $368.0 $48.2 Million - $97.6 Million
265,200 Added 52.73%
768,100 $142 Million
Q1 2022

May 16, 2022

SELL
$303.87 - $423.8 $60.6 Million - $84.5 Million
-199,500 Reduced 28.4%
502,900 $176 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $20.5 Million - $24.9 Million
59,000 Added 9.17%
702,400 $267 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $192 Million - $248 Million
472,700 Added 276.92%
643,400 $261 Million
Q2 2021

Aug 16, 2021

BUY
$372.84 - $481.5 $57.5 Million - $74.3 Million
154,300 Added 940.85%
170,700 $80.8 Million
Q1 2021

May 17, 2021

SELL
$361.28 - $504.76 $14.7 Million - $20.5 Million
-40,600 Reduced 71.23%
16,400 $6.3 Million
Q4 2020

Feb 16, 2021

BUY
$292.7 - $370.96 $8.31 Million - $10.5 Million
28,400 Added 99.3%
57,000 $21.1 Million
Q3 2020

Nov 16, 2020

SELL
$268.51 - $400.74 $53,702 - $80,148
-200 Reduced 0.69%
28,600 $8.84 Million
Q2 2020

Aug 14, 2020

BUY
$256.46 - $373.01 $5.82 Million - $8.47 Million
22,700 Added 372.13%
28,800 $10.7 Million
Q1 2020

May 15, 2020

BUY
$209.2 - $335.53 $1.28 Million - $2.05 Million
6,100 New
6,100 $1.67 Million
Q1 2019

May 15, 2019

SELL
$272.57 - $321.18 $681,425 - $802,950
-2,500 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$272.46 - $366.54 $2.17 Million - $2.92 Million
-7,980 Reduced 76.15%
2,500 $750,000
Q3 2018

Nov 14, 2018

BUY
$279.04 - $367.06 $2.92 Million - $3.85 Million
10,480 New
10,480 $3.85 Million
Q1 2018

May 15, 2018

SELL
$209.54 - $253.91 $3.33 Million - $4.03 Million
-15,880 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$202.23 - $230.03 $15.9 Million - $18.1 Million
-78,762 Reduced 83.22%
15,880 $3.47 Million
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $16.3 Million - $20.2 Million
94,642
94,642 $18.9 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $24.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.